BIO will provide two days of insightful, interactive panels and fireside chats from the leading biopharma executives and investors creating the next wave of medicines in the dynamic global environment for drug development.

Topics under consideration include:

• How are Global Trade Macroeconomics Impacting US Venture Investing and M&A Trends? 
• Best Practices for Family Office Participation in Syndicating Venture Rounds 
• Market Outlook: What Would IPO Success in 2026 Require?
• Washington Policy Briefing: FDA’s and CMS’s Newest Initiatives
• Supply Chain and Valuation Strategies for a Tariff Economy
• New Investor Liabilities for Cross-Border Data Security
• Advances in Immunology and Inflammation and Opportunities for Investment
• Differentiating Obesity, Cardiometabolic, and Longevity Treatment Pipelines 
• Biotech White Spaces: Charting the Frontier Platforms in Therapeutic Development
• Advances for Neuropsychiatric Treatments and Targets